Phase 3 Study of the Efficacy and Safety of Therapy During Induction and Maintenance in Patients with Moderate to Severe Active Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

August 22, 2018
https://clinicaltrials.gov/ct2/show/NCT02100696
Gastroenterology Hepatology
Principal Investigator: Nirmal Kaur, MD
UC, uc, ulcerative colitis, active ulcerative colitis, tnf, TNF, IBD
Open